Risks of anticoagulant therapy in pregnant women with artificial heart valves

The New England Journal of Medicine
I Iturbe-AlessioE Salazar

Abstract

In an attempt to identify the best treatment for pregnant women with cardiac-valve prostheses who are receiving oral anticoagulants, we studied 72 pregnancies prospectively. In 23 pregnancies (Group I), the coumarin derivative acenocoumarol was discontinued and the patients received 5,000 U of subcutaneous heparin every 12 hours from the 6th to the 12th week of gestation, in 12 pregnancies (Group II), heparin was not substituted for the coumarin derivative until after the 7th week, and in 37 pregnancies, detected after the first trimester (Group III), the coumarin derivative was given throughout gestation. In most patients heparin was again substituted for the oral anticoagulant after the 38th week. Three mothers had thrombosis of a tilting-disk mitral prosthesis (two cases were fatal) during heparin treatment. No differences were found in the rates of spontaneous abortion in the three groups. Coumarin embryopathy occurred in 25 percent and 29.6 percent of the pregnancies in Groups II and III, respectively. We conclude that in the second and third trimesters of pregnancy, coumarin derivatives provide effective protection against thromboembolism while causing few fetopathic effects, but that these agents are contraindicated from...Continue Reading

References

Oct 23, 1976·Lancet·W HolzgreveB D Hall
Dec 1, 1979·Clinical Obstetrics and Gynecology·R K Laros, L S Alger
Jun 3, 1978·British Medical Journal·G SpearingG Dixon
Jun 15, 1978·American Journal of Obstetrics and Gynecology·D J LutzC R Fish
Apr 1, 1977·The Annals of Thoracic Surgery·R Limet, C M Grondin
Nov 1, 1977·Acta paediatrica Scandinavica·K O RaivioS Saarikoski
Nov 1, 1976·British Heart Journal·C Oakley, P Doherty
Jun 1, 1985·Annals of Internal Medicine·A I Schafer
Mar 23, 1968·Lancet·G G Bennett, C M Oakley
Mar 1, 1972·American Heart Journal·J HirshA S Gallus
Jun 1, 1971·Chest·A BuxbaumB Ekerling
Jan 31, 1970·British Medical Journal·J HirshE F O'Sullivan
Dec 1, 1983·British Journal of Obstetrics and Gynaecology·R HowellM de Swiet
Nov 1, 1984·British Journal of Obstetrics and Gynaecology·M K ChongM de Swiet
Oct 1, 1983·The Annals of Thoracic Surgery·J L LarreaJ A Minguez
Jul 1, 1983·Clinical Pharmacology and Therapeutics·L R WhitfieldG Levy
Jan 1, 1980·The American Journal of Medicine·J G HallK M Wilson
Jul 1, 1982·The Annals of Thoracic Surgery·L H Edmunds
Jan 1, 1982·Gynecologic and Obstetric Investigation·M Hellgren, E B Nygårds
Apr 18, 1980·JAMA : the Journal of the American Medical Association·R E StevensonH A Taylor
Sep 1, 1965·American Journal of Obstetrics and Gynecology·U VILLASANTA

❮ Previous
Next ❯

Citations

Sep 5, 1997·American Journal of Medical Genetics·A M HoweW S Webster
Aug 1, 1990·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R FeteihJ B Lian
Nov 1, 1988·Journal of General Internal Medicine·J L Carson, D L Elliot
Jan 5, 2001·Current Treatment Options in Cardiovascular Medicine·L Mauri, P T O'Gara
Jan 1, 1989·American Journal of Obstetrics and Gynecology·L TengbornU Hedner
Jun 1, 1989·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M BitschM Osler
Jul 1, 1990·European Journal of Obstetrics, Gynecology, and Reproductive Biology·J TapanainenP Salmela
Mar 31, 1994·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A CarusoA Pompei
Mar 24, 1995·International Journal of Cardiology·M GalleraniS Moratelli
Jun 1, 1996·Journal of the American College of Cardiology·U R Elkayam
Mar 1, 1994·Reproductive Toxicology·S Pati, G D Helmbrecht
Apr 1, 1996·Disease-a-month : DM·N Futrell, C H Millikan
Oct 18, 2002·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·D Blickstein, I Blickstein
Feb 20, 2003·Thrombosis Research·Shannon M Bates
Oct 29, 1994·Lancet·J S Ginsberg, W M Barron
Aug 1, 1997·European Journal of Obstetrics, Gynecology, and Reproductive Biology·G DaskalakisS Michalas
Jul 3, 1999·European Journal of Obstetrics, Gynecology, and Reproductive Biology·F RobinR Taurelle
Jun 16, 2001·Early Human Development·J WesselingB C Touwen
May 20, 1999·Journal of the American College of Cardiology·N VitaleM Cotrufo
May 14, 1999·Cardiology in the Young·A A SchmaltzU H Winkler
Sep 5, 2001·Acta Obstetricia Et Gynecologica Scandinavica·A AyhanR Dogan
May 16, 2012·Nature Reviews. Cardiology·Jose M CastellanoValentin Fuster
Jun 3, 1998·British Journal of Haematology
Aug 17, 1999·Clinical and Laboratory Haematology·P J CampbellK E Ryan
Jun 27, 1991·The New England Journal of Medicine·J Hirsh
Aug 8, 1996·The New England Journal of Medicine·W VongpatanasinR A Lange
Jun 23, 1999·Heart·S S MeschengieserM A Lazzari
Aug 19, 2004·Cardiology in Review·Shadi A QasqasUri Elkayam
Dec 20, 2005·Obstetrical & Gynecological Survey·Andra H JamesLeo R Brancazio
Jan 30, 2010·Critical Care Medicine·Andra H James
Jul 26, 2012·Clinical Obstetrics and Gynecology·Andra H James
Sep 1, 1993·British Journal of Obstetrics and Gynaecology·T W de VriesH S Heijmans
Aug 6, 1998·British Journal of Obstetrics and Gynaecology·R Frewin, M Chisholm
Aug 6, 1998·British Journal of Obstetrics and Gynaecology·D WellesleyB Keeton
Apr 1, 1994·Acta Paediatrica·D P BarkerJ A Richardson
Oct 1, 1987·British Heart Journal·C Oakley
May 1, 1988·British Heart Journal·N C CowanM T Rothman
Feb 1, 1994·British Heart Journal·E Sbarouni, C M Oakley
Aug 1, 1995·British Heart Journal·C M Oakley
May 1, 2004·Circulation Journal : Official Journal of the Japanese Circulation Society·Tsuyoshi FukudaEiji Koike
Mar 1, 1996·Acta Obstetricia Et Gynecologica Scandinavica·F LecuruR Taurelle
Jul 25, 2007·Annals of Cardiac Anaesthesia·Aseem R SrivastavaAmit Banerjee
Dec 5, 2013·Thrombosis·Tsuyoshi Kaneko, Sary F Aranki
Mar 15, 2012·Future Cardiology·Rachael HattonCandice K Silversides

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.